TC Medical(SH:600763) Sou Hu Cai Jing·2025-12-29 11:27Group 1 - The core viewpoint of the article highlights the financial performance and stock activity of Tongce Medical (600763) as of December 29, 2025, with a closing price of 40.55 yuan, reflecting a decrease of 0.93% [1] - The company reported a main revenue of 2.29 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 2.56% [2] - The net profit attributable to shareholders for the same period was 514 million yuan, up 3.16% year-on-year, while the net profit excluding non-recurring items was 509 million yuan, increasing by 3.09% [2] Group 2 - In Q3 2025, the company achieved a single-quarter main revenue of 842 million yuan, which is a 2.34% year-on-year increase [2] - The net profit attributable to shareholders for Q3 2025 was 192 million yuan, reflecting a year-on-year growth of 2.31% [2] - The company has a debt ratio of 25.1% and reported investment income of 41.22 million yuan, with financial expenses amounting to 31.93 million yuan and a gross profit margin of 41.69% [2] Group 3 - The stock experienced a net outflow of 19.18 million yuan from main funds, accounting for 11.06% of the total transaction amount, while retail investors saw a net inflow of 11.71 million yuan, representing 6.75% of the total [1] - Over the past 90 days, seven institutions have provided ratings for the stock, with four giving a buy rating and three an increase rating, while the average target price set by institutions is 5.29 billion yuan [2]